Background: The importance of a holistic approach with a comprehensive multidisciplinary team, including nutritional and psychosocial support, is becoming well recognised as a key contributor to optimal care in paediatric inflammatory bowel disease [IBD]. The Paediatric committee of ECCO [P-ECCO] aimed to determine important components that would contribute to quality of care in a paediatric IBD centre [henceforth 'quality items']. Methods: First, a list of items has been generated by a Delphi group of 111 international paediatric IBD experts. Through an iterative process, the group graded and ranked the items according to their perceived relative contribution to quality care. We then surveyed 101 paediatric IBD centres affiliated with the Porto and Interest groups of ESPGHAN in Europe and with the ImproveCareNow registry in North America, exploring the availability of the retained items in their centres. Results: A total of 68 items were generated and reduced to a list of 60 ranked order items, grouped in six domains: Facility, Personnel, Management, Supportive Services, Patient Support and Accessibility, and Academia and Communications. Of the retained items, 52 [88%] were present in most of the 101 high-performing paediatric IBD centres, and there was a trend for increased availability with increased patient volume at the centres. Conclusion: In this P-ECCO study, we attempted to tabulate, for the first time in paediatrics, 60 quality items that paediatric IBD referral centres may wish to include.
Introduction
Managing inflammatory bowel diseases [IBD] is a complex process, especially in children who more often have a severe disease and pose age-specific challenges. The move towards personalised medicine, and the advent of new therapies and increasing numbers of diagnostic modalities, require access to a diverse multidisciplinary team [MDT] with expertise in the different aspects of the disease. 1, 2 There is a significant gap between the ideal IBD management recommendations as stated in international guidelines and the dayto-day clinical practice. 3, 4 Patients often receive suboptimal dosing of immunomodulators and 5-aminosalicylic acid medications, as well as prolonged courses of corticosteroids. 5 Many do not undergo appropriate infectious screening and there is significant variation in treatment algorithms between centres. 6, 7 The problem is worse in paediatrics since altogether the number of children with IBD is only ~ one-tenth of that seen in adults. This leads to paediatric centres that have fewer patients and many do not attain a critical mass of patients to justify dedicated resources. Additionally, paediatric-onset disease is more extensive and its course is often more challenging to manage. [8] [9] [10] The presence of pubertal delay, growth impairment, and osteopenia typically requires an early-intensified management towards promoting mucosal healing. In these cases, the use of nutritional therapy is particularly attractive, requiring a specialised team. The use of support groups and other psychosocial interventions is advocated as a means to develop coping skills and improve quality of life. Non-adherence to medications is another significant treatment barrier in paediatric IBD, very frequently reported in adolescents. 11 Therefore, a particular emphasis should be placed on engaging the adolescent in the treatment plan while enhancing gradual transition to adulthood which requires specialised allied medical personnel.
A recent survey of 142 adult physicians with an interest in IBD found that many IBD centres lack important specialists such as dedicated IBD nurses [38% lacking], stoma specialists [38%], psychologist/social services [34%], and imaging consults [15%]. 12 Only 49% of the responders stated that their centre has defined treatment algorithms for the treatment of IBD. In attempts to better standardise current practice, previous publications have recommended a list of quality indicators for adult IBD centres. [12] [13] [14] However, no such an attempt has been made in paediatrics.
In this ECCO [European Crohn's and Colitis Organisation] project, we aimed to identify important quality items required in paediatric IBD centres, using a Delphi process of paediatric gastroenterologists and a survey of specialised paediatric IBD centres.
Methods
The Paediatric committee of ECCO [P-ECCO] formed a Delphi group to define quality items recommended for establishing specialised paediatric IBD centres. A total of 190 members of the Paediatric IBD Porto and Interest groups of ESPGHAN, P-ECCO, and selected members from the Paediatric GI Bulletin Board, were invited to join the Delphi group, of whom 111 agreed to participate; 59 provided input to all three rounds [Appendix 2, available as Supplementary data at ECCO-JCC online]. Since we were looking for physicians experienced in treating children with IBD, we included only those treating at least 50 IBD children [< 18 years of age] at a time or they were diagnosing 10 new IBD children per year.
Item generation and grading
A list of all possible quality items was first generated by the P-ECCO committee, based on experience and published literature [cited in the The domain-grouped list was re-sent to the Delphi participants asking them to score the importance of each item on a scale of 1 to 5, where 1 indicated very important and 5 least important for an IBD paediatric centre. The steering committee rank-ordered the items within each domain using each item's mean importance value and removed the lowest ranked items. There was no a priori threshold for excluding an item, but rather a judgmental decision of the steering committee based on the individual component.
Next, each Delphi participant ordered the final list of items within each domain from the most important to the least important, leading to the final order of the items.
Item frequencies in a real-life cohort of IBD centres
We then sought to examine the availability of the final list of items in many high-performing centres from Europe and North America. These were selected from the Paediatric IBD Porto and Interest groups of ESPGHAN in Europe and the ImproveCareNow [ICN] registry in North America. We assumed that there would be a correlation between the volume of the centre and the availability of quality items in that centre. We thus compared the availability of items in the low-and high-volume centres [< 100 and > 300 patients, respectively], in an extreme group analysis.
Association of the items with disease outcomes in the ICN registry
Every participating ICN centre submits data to the registry from each outpatient visit of every IBD patient consented for ICN. These data include physician global assessment of disease activity, anthropometric measures, current medications, abbreviated paediatric Crohn's disease activity index [abbrPCDAI] or paediatric ulcerative colitis activity index [PUCAI] , and laboratory results. These data allowed us to record the outcomes of the patients registered in each of the 39 ICN centres, as documented in the ICN database. We examined the relationship between the outcome data and the availability of the quality items reported in the survey at a site level. We examined three outcome measures over time between January and June 2015: the percentage of patients in clinical remission [determined by the abbrPCDAI or the PUCAI 15, 16 ], the percentage of patients in steroidfree remission, and the percentage of patients in sustained remission.
Statistical analyses
Summary data are presented as item-level frequencies [%], means ± standard deviation, or medians (interquartile range [IQR]), as appropriate. Availability of the items in the different volume sites was compared using the chi square. For the outcome analyses, we estimated cross-sectional item-level polyserial correlations between each item and each outcome. The polyserial correlations provide the estimated correlation between the continuum underlying the ordinal item responses and values on the continuous outcome. We also estimated a series of longitudinal growth models examining the relationship between each site-level domain score and the site-level outcome across time. 17 The longitudinal growth models properly account for the longitudinal nature of the data and provide the average value of the outcome at the observation period's start, the average relationship between the domain scores and the outcomes, and the extent to which each outcome changed across time at average levels of each domain score. To control for the inflated type I error possibility that occurred as a result of multiple inferential tests, we followed the Benjamini-Hochberg approach which controls the false-discovery rate. 
Results

Generation of the item list by the Delphi group
First, 59 quality items were listed by the steering committee and sent to the Delphi group members who added nine more items. The 68 items were re-sent to the group who graded each for relative importance, from 1 to 5. Based on this second round, the steering committee decided to exclude the lowest ranked eight items [ Table 1 footnote]. The exclusion of these items does not mean that they are not important, but rather that they are not significant enough to be included in a list of crucial items. The ranked list of items was re-sent to the Delphi group, asking them to order the items within each domain from the most important to the least important [ Table 1 ]. Some of the highest-ranked items were: 'The centre treats at least 10 new IBD children per year or 50 children at any given time'; 'The centre has access to faecal inflammatory markers'; 'The centre has a dedicated stand-alone weekly IBD clinic where only children with IBD are seen'; 'The centre has at least one physician who leads the IBD care, and is updated on current literature'; 'The centre can accommodate urgent outpatient clinics'; and 'The centre has a 24/7 helpline'. Excluded items [all with scores under 3.2]: patient self-management support, active patient registry, ophthalmology screening protocols, a dedicated person to ensure academic assistance when needed, quality improvement team, pre-visit planning, population management using registry-generated reports, internet service for families.
Item frequencies in a real-life cohort of paediatric IBD centres
IBD, inflammatory bowel disease; ICN, IMproveCareNow; TPMT, thiopurine S-methyltransferase; ERCP, endoscopic retrograde cholangio pancreatography; HBV, hepatitis B virus; MRE, magnetic resonance enterography; CTE, computed tomography enterography; US, ultrasound; MRCP, magnetic resonance cholangiopancreatography; DEXA, dual-energy x-ray absorptiometry; qCT, quantitative computed tomography.
a Represents the mean grading of the Delphi group in round 2 [ie, each item was scored 1-5 where higher scores indicate higher importance]. b Represents the mean ordering of the Delphi group in round 3 [ie, all retained items in the grading round 2 have been ordered from the most to the least important where higher scores indicate higher importance]. Table 1 . Continued participate and completed a survey indicating which of the quality items determined by the Delphi group are available in their centre [ Table 1 ]. The size of the centres was comparable between the two sources [ Figure 1 ]. Of the 60 included items, 52 [87%] were scored by most sites as available in their IBD centres, lending support for their importance [ Table 1 ]. Notable items that were not frequently available were: stand-alone weekly IBD clinic where only children with IBD are seen, IBD nurse, and family feedback on the quality of service they receive. The following items were regularly lacking mainly in North America-support programme for the children, transition clinics, bowel ultrasound, and attendance of annual IBD academic meetings. Europe centres were less strong on 24/7 helpline and active surveillance of the patients' status, including monitoring the rate of patients in remission and maintaining an active database of disease activity.
Association of the items with centre volume
We then explored whether the size of the centre is associated with the eight items which were available in the minority of centres [ Table 1 ]. Almost all eight items were numerically more prevalent in the large-volume sites [> 300 patients] than the small sites [< 100 patients] but, given the small sample size, only the availability of IBD nurses reached statistical significance (16 [67%] vs 5 [25%], respectively; p = 0.015).
Association of the items with disease outcomes in the ICN registry
Despite a numerical trend, the quality items and domains did not significantly predict outcomes among the 39 ICN centres, likely due to the low item-level variation and the small sample size. The polyserial correlations between item responses and outcomes ranged [absolute value] from 0 to 0.71. The mean polyserial correlations for the three chosen outcomes-remission, prednisone free remission, and sustained remission─were 0.26, 0.25, and 0.17, with standard deviations [SDs] of 0.23, 0.23, and 0.14, respectively. We also estimated several longitudinal growth models that separately examined whether each domain score and the individual items predicted outcomes across time, but none of the parameters was statistically significant.
Discussion
In this study, we tabulated for the first time in paediatrics, 60 items that paediatric IBD centres of quality may elect to include. Using a large Delphi group of paediatric IBD experts, we ranked these items according to their perceived importance. We then surveyed 101 paediatric IBD centres affiliated with ESPGHAN in Europe and with the ICN registry in North America, and found that the vast majority of the 60 items were available in most of these high-performing paediatric IBD centres and that there was a trend for higher availability with higher centre volume. We could not correlate the availability of the items by the ICN centres with patients' clinical outcomes as recorded in that registry, likely because of the small sample size and since the ICN registry have less variation in care, due to shared protocols.
The high availability of the items in the 101 paediatric IBD centres provides some internal validity to the Delphi group choice of the items, since the included IBD centres are among the leading centres worldwide. On the other hand, the fact that many of these leading centres did not have many of the items points to a gap in resources that may need to be addressed on an individual level. Some of the items that were mostly unavailable were: dedicated stand-alone IBD clinics, 24/7 helpline, transition clinics, dedicated IBD nurse, support programmes for the children and their families, and the availability of bowel ultrasound. Other pertinent items, such as the availability of a dietician, access to drug levels, and faecal calprotectin, seem adequately endorsed by the surveyed centres. However, our results may not be generalised to smaller community centres.
Resources required for hiring a professional MDT and organising specialised IBD clinics while promoting academia, research, and local management protocols, can be more easily justified in high-volume centres that treat many patients. In turn, high-volume admission centres have been associated with improved survival in IBD patients undergoing surgery. 12 Caring for IBD patients in a dedicated MDT centre has been shown to increase the expertise of the clinicians and improve clinically important outcomes. 2, 19 A statement of 224 voting adult-IBD experts indicated that in addition to a gastroenterologist and a colorectal surgeon, the MDT should include an IBD specialist nurse, nutritionist, stoma specialist, radiologist, endoscopist, pathologist, psychologist, and social worker, all with IBD experience. 12 Several other aspects of an IBD centre may improve clinical care including a 24/7 helpline, transition Number of children treated in the IBD center % of pediatric IBD centers n=4 n=9 n=11 n=33 n=5 n=6 n=2 n=5 n=10 n=8 n=4 n=4 Figure 1 . Distribution of paediatric IBD centres which participated in our survey according to the number of children followed in that centre.
clinic, structured weekly clinical rounds, establishment of local treatment algorithms, regular self-assessment of clinically important outcomes, ensuring an interactive patient registry, and performing IBD-related research. 12 A dedicated IBD nurse may improve patient outcomes including fewer hospital admissions 20 and better quality of life. 21 Formal IBD patient education programmes improve knowledge and patient satisfaction, 22 and support programmes may build resilience. 23 A structured transition programme could reduce complications occurring during this sensitive period of transfer to adult care. 24 A recent paediatric study showed that pre-visit planning may be associated with a slight increase of remission rates in children with IBD. 25 However, not all IBD centres have the required resources to provide these services, especially in small centres. Future studies may need to focus on which of the quality items should be included also in smaller centres and which could be reserved only to the larger referral ones. This paper is not without limitations. The Delphi process may be biased towards the availability of resources in the centres affiliated with the participants and not necessarily the most important items. However, we attempted to address this limitation by ensuring cultural and geographical diversity; the Delphi participants were from across Europe, Israel, the USA, Canada, and Australia. A novel attempt to use real-life outcome data from the ICN registry for further weighting the included items failed, due to insufficient variation between the centres explained by the fact that all ICN are located within the USA and share similar protocols. Further studies will be needed to validate the list of chosen items against clinical outcomes.
Formal IBD multidisciplinary centres and proactive management may reduce disease burden and improve outcomes. The benefits may be even more pronounced in children given their smaller population, more extensive disease, many future disease-related years, and agespecific challenges. A critical mass of patients is mandatory to offer the structural services described in this paper and to allow enough experience for specialised personnel. We are hopeful that the P-ECCO quality items project will promote standardisation of the care children with IBD receive globally, while setting the bar at a minimal accepted standard. We call for each country to survey its centres for the availability of the quality items identified here, and to set forth individual plans for establishing local specialised paediatric IBD centres.
